|
[Related PubMed/MEDLINE] Total Number of Papers: 9
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: hERG |
Long Form |
: human ether-a-go-go gene |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
New Insights into Ion Channels: Predicting hERG-Drug Interactions. |
NCE, SAR |
2 |
2021 |
Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition. |
D. orbita, FDA, MM-PBSA, PK, Rg, RMSD, RMSF, SASA, TK |
3 |
2020 |
Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs. |
COVID-19, FDA, LQTS, SARS-CoV-2, TdP |
4 |
2014 |
Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population. |
ECG |
5 |
2013 |
Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs. |
--- |
6 |
2008 |
A novel nonsense mutation Y652X in the S6/pore region of human ether-go-go gene found in a long QT syndrome family. |
NMD, PCR |
7 |
2004 |
Suppression of electrical alternans by overexpression of HERG in canine ventricular myocytes. |
CLs |
8 |
2002 |
The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels. |
--- |
9 |
2002 |
Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. |
--- |
|